You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 12, 2024

FML - Profile


✉ Email this page to a colleague

« Back to Dashboard


US Patents and Regulatory Information for FML

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan FML fluorometholone OINTMENT;OPHTHALMIC 017760-001 Sep 4, 1985 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Allergan FML-S fluorometholone; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 019525-001 Sep 29, 1989 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbvie FML fluorometholone SUSPENSION/DROPS;OPHTHALMIC 016851-002 Jul 28, 1982 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbvie FML FORTE fluorometholone SUSPENSION/DROPS;OPHTHALMIC 019216-001 Apr 23, 1986 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.